Sullivan & Cromwell-Led Merck To Buy SpringWorks For $3.9B
By Tom Fish · April 28, 2025, 1:06 PM BST
Merck KGaA said Monday it has agreed to acquire U.S. biotech company SpringWorks Therapeutics for $3.9 billion, as the German science and technology group aims to grow its cancer drug business...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login